Abstract
Congestive heart failure (CHF) is now the leading discharge diagnosis for patients hospitalized in the United States and is a major human health problem. Although advances in medical therapy have improved survival rates and the quality of life for patients with CHF, definitive treatment is presently very limited, in large part due to an inability of the heart to repair itself through proliferation of reserve cells. Currently definitive therapeutic regimens for CHF include cardiac transplantation, which is limited by a shortage of donor subjects and a necessity for high-dose immunosuppression; and treatments such as cardiomyoplasty and extraventricular assist devices, which are limited by a lack of effectiveness in many patients. With the advent of gene transfer technology, new therapies for treating cardiovascular disease may become feasible. Our laboratory is developing two promising approaches to treat cardiovascular disease. The first involves introducing autologous, biopsy-derived skeletal muscle reserve cells (myoblasts) into the myocardium to augment contractile function (myoblast transfer therapy). The second utilizes myoblasts as a vector to deliver potentially therapeutic genes locally to the damaged myocardium (myoblast-mediated gene therapy). We will discuss the advantages that these approaches offer over current treatments for cardiovascular disease and other gene therapy techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ascadi G, Jiao S, Jani A, et al.: Direct gene transfer and expression into rat heart in vivo.New Biol 1991;3(1):71–81.
Banai S, Jaklitsch MT, Shou M, et al.: Angiogenic-Induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1993;89:2183–2189.
Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991;254:1507–1509.
Bischoff R: Regeneration of single skeletal muscle fibers in vitro.Anat Rec 1975; 182:215–236.
Carpentier A, Chachques JC, Acar C, et al.: Dynamic cardiomyoplasty at seven years. J Thorac Cardiovasc Surg 1993;106(1):42–52.
Chamey R, Cohen M: The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 1993;126:937–945.
Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo S: Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 1993;90(24):11548–11552.
Cserjesi P, Olson EN: Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol 1991;11(10):4854–4862.
Dai Y, Roman RK, Verma IM: Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.Proc Natl Acad Sci USA 1992;89:10892–10895.
Delcarpio JB, Barbee RW, Perry BD, Claycomb WC: Cardiomyocyte transfer into the rat and mouse heart. J Cell Biochem 1993;17D:210.
Engel AG, Franzini-Armstrong C: Myology (Second ed.). New York: McGraw-Hill, Inc., 1994: 1938.
Engelhardt JF, Ye X, Doranz B, Wilson JM: Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response. Proc Natl Acad Sci USA 1994;91(13):61196–61200.
Feghali R, Karsch-Mizrachi I, Leinwand L, Kohtz DS: Four myosin heavy chain genes are expressed by human fetal skeletal myoblasts differentiating in culture. GeneExpr 1990;2((1)):49–58.
Fire A: Histochemical techniques for locating escherichia coli β-galactosidase activity in transgenic organisms. Gen Anal: Tech & Appl 1992;9:151–158.
Gosset LA, Kelvin DJ, Stemberg EA, Olson EN: A new myocyte-specific enhancer-binding factor that recognozes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol 1989;9(11):5022–5033.
Gussoni E, Pavlath GK, Lanctot AM, et al.: Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992;356:435–438.
Harada K, Grossman W, Friedman M, et al.: Basic fibroblast growth factor improves myocardial function in chronically ischemie porcine hearts. J Clin Invest 1994;94:623–630.
Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:883–893.
Jugdutt BJ, Becker LC, Hutchins GM, Buckley BH, Reid PR, Kallman CH: Effects of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog. Circulation 1981;63:17–28.
Kass-Eisler A, Flack-Pederson E, Alvira M, et al.: Quantitative determination of adenovirusmediated gene delivery to rat cardiac myocytes in vitro and in vivo.Proc Natl Acad Sci USA 1993;90:11498–11502.
Kitsis RN, Buttrick PM, McNally EM, Kaplan ML, Leinwand LA: Hormonal modulation of a gene injected into rat heart in vivo.Proc Natl Acad Sci USA 1991;88:4138–4142.
Koh GY, Soonpa MH, Klug MG, Field LJ: Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol 1993;264 (Heart Circ Physiol 33):H1727-H1733.
Kohtz DS, Cole F, Wong M-L, Hsu MT: Infection and inhibition of differentiation of human skeletal myoblasts by adenovirus. Virol 1991;184:569–579.
Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM: In vivo correction of low density lipoprotein recpetor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994;269(18): 13695–13702.
Kozarsky KF, Wilson JM: Gene therapy: adenovirus vectors. Curr Opin Gen Dev 1993;3:499–503.
Law PK, Bertorini TE, Goodwin TG, et al.: Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Nature 1990;336(July 14):114–115.
Magovern JA, Magovern GJJ, Magovern GJ, Palumbi MA, Orie JE: Surgical therapy for congestive heart failure: indications for transplantation versus cardiomyoplasty. J Heart Lung Transplant 1992;11(3 Pt 1):538–544.
Mauro A: Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9:493–495.
Michels VV, Moll PP, et al.: The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77–82.
Milano CA, Allen LF, Rockman HA, et al.: Enhanced Myocyte Function in Transgenic Mice Overexpressing β 2-Adrenergic Receptor. Science 1994;266:507–508.
Morgan JE Moore, SE, Walsh, FS, Partridge, TA: Formation of skeletal muscle in vivo from the mouse C2 cell line. J Neurolog Sci 1992;115:191–200.
Prentice H, Kloner RA, Sartorelli V, Bellows SD, Alker K, Kedes L: Transformation of cardiac fibroblasts into the skeletal muscle phenotype by injection of a MyoD-expressing retrovirus into ischémie heart. Circulation 1993;88(4):I–476.
Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD: Transcriptional regulation of the rat platelet factor 4 gene: Interaction between and enhancer/silencer domain and the GATA site. Mol Cell Biol 1991;11(12):6116–6127.
Robinson S, Cho PW, Levitsky HI, Hruban RH, Acker MA, Kessler PD: Vascular delivery of recombinant skeletal myoblasts to the myocardium. Circulation 1993;88(4):I–476.
Robinson SW, Cho PC, Acker MA, Kessler PD: Arterial delivery of skeletal myoblasts to the heart. J Cell Biochem 1994;18D:531.
Russell DW, Miller AD, Alexander IE: Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994;91(19):8915–8919.
Samulski RJ: Adeno-associated virus: integration at a specific chromosomal locus. Curr Opin Genet Dev 1993;3(1):74–80.
Schaper W, De Brabander M., Lewi P: DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971;28:671–679.
Schaper W, Flameng W, Winkler B, et al.: Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog. Circ Res 1976;39:371–377.
Schiaffino S, Bormioli SP, Aloisi M: The fate of newly formed satellite cells during compensatory muscle hypertrophy. Virchows Arch [B] 1976;21:113–118.
Soonpaa MH, Koh GY, Klug MG, Field LG: Formation of nascent intercalated disks between grafted cardiomyocytes and host myocardium. Science 1994;264:98–101.
Taylor DA, Kraus WE: Primary rabbit skeletal myoblasts as a tool for gene therapy. In Vitro Cell Dev Biol 1994;30A (Part II Hot Topics).
Towbin JA, Hejtmancik F: X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne Muscular Dystrophy (dystrophin) gene at the Xp2 locus. Circulation 1993;87:1854–1865.
Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL: Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993;2(2):99–112.
Unger EF, Banai S, Shou M, et al.: Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266:H1588–H1595.
Webster C, Pavlath GK, Parks DR, Walsh FS, Blau HM: Isolation of human myoblasts with the fluorescence-activated cell sorter. Exper Cell Res 1988; 174:252–265.
Wernig A, Irintchev A, Hartling A, Stephan G, Zimmerman K, Starzinski-Powitz A: Formation of new muscle fibers and tumours after injection of cultured myogenic cells. J Neurocytol 1991;20:982–997.
Wolff JA, Malone RW, Williams P, et al.: Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465–1468.
Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al.: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401–1403.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Taylor, D.A., Annex, B.H., Kraus, W.E., Bishop, S.P., Silvestry, S.C. (1997). Skeletal Myoblast Therapy in Cardiovascular Disease. In: March, K.L. (eds) Gene Transfer in the Cardiovascular System. Developments in Cardiovascular Medicine, vol 189. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6277-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6277-1_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7881-5
Online ISBN: 978-1-4615-6277-1
eBook Packages: Springer Book Archive